COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 281: Articles 2801-2810  | Next

SARS-CoV-2 antibodies cross-react and enhance dengue infection
Jakhar, K., Sonar, S., Singh, G., Sarkar, T., Tiwari, M., Kaur, J., Rathore, D. K., Lal, B., Kumar, S., Srivastav, P., Kumar, S., Phagna, V., Kumar, L., Gupta, V., Kshetrapal, P., Singh, S., Wadhwa, N., Thiruvengadam, R., Raghavan, S., Gosain, M., Shrivastava, T., Bhattacharyya, S., Bhattacharya, J., Asthana, S., Mani, S.
10.1101/2023.10.09.557914 — Posted: 2023-10-10
Deep learning-guided selection of antibody therapies with enhanced resistance to current and prospective SARS-CoV-2 Omicron variants
Frei, L., Gao, B., Han, J., Taft, J. M., Irvine, E. B., Weber, C. R., Kumar, R., Eisinger, B., Reddy, S. T.
10.1101/2023.10.09.561492 — Posted: 2023-10-10
Clinical impact and cost-effectiveness of the updated COVID-19 mRNA Autumn 2023 vaccines in Germany
Joshi, K., Scholz, S., Maschio, M., Kohli, M., Lee, A., Fust, K., Ultsch, B., van de Velde, N., Beck, E.
10.1101/2023.10.09.23296505 — Posted: 2023-10-10
Non-pharmacological interventions aimed at promoting the mental health of children and adolescents during the COVID-19 pandemic
Quiroga, C. V., Caobelli, A. C. S. L., Rodrigues, G. V. A., Viola, T. W.
10.1101/2023.10.07.23296694 — Posted: 2023-10-09
Immunomodulators and risk for breakthrough infection after third COVID-19 mRNA vaccine among patients with rheumatoid arthritis: A cohort study
Schiff, A. E., Wang, X., Patel, N. J., Kawano, Y., Kowalski, E. N., Cook, C. E., Vanni, K. M. M., Qian, G., Bade, K. J., Saavedra, A. A., Srivatsan, S., Williams, Z. K., Venkat, R. K., Wallace, Z. S., Sparks, J. A.
10.1101/2023.10.08.23296717 — Posted: 2023-10-09
Effects of COVID-19 mRNA vaccination on HIV viremia and reservoir size
Duncan, M. C., Omondi, F. H., Kinloch, N. N., Lapointe, H. R., Speckmaier, S., Moran Garcia, N., Lawson, T., DeMarco, M. L., Simons, J., Holmes, D. T., Lowe, C. F., Bacani, N., Sereda, P., Barrios, R., Harris, M., Romney, M. G., Montaner, J. S. G., Brumme, C. J., Brockman, M. A., Brumme, Z. L.
10.1101/2023.10.08.23296718 — Posted: 2023-10-09
Impact of sampling site on diagnostic test accuracy of RT-PCR in diagnosing Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection since the emergence of omicron: a systematic review and meta-analysis
Saal-Bauernschubert, L., Wagner, C., Fomenko, A., Daehne, T., Bora, A.-M., Janka, H., Stangl, S., Skoetz, N., Weibel, S.
10.1101/2023.10.09.23296728 — Posted: 2023-10-09
Covid-19 vaccine safety in pregnancy, a nested case-control study in births from April 2021 to March 2022, England
Mensah, A. A., Stowe, J., Jardine, J. E., Kirsebom, F. C., Clare, T., Kall, M., Campbell, H., Lopez-Bernal, J., Andrews, N.
10.1101/2023.10.09.23296737 — Posted: 2023-10-09
Unravelling Causal Associations between Population Mobility and COVID-19 Cases in Spain: a Transfer Entropy Analysis
Ponce de Leon, M., Pontes, C., Arenas, A., Valencia, A.
10.1101/2023.10.09.23296732 — Posted: 2023-10-09
The SARS-CoV-2 Spike is a virulence determinant and plays a major role on the attenuated phenotype of Omicron virus in a feline model of infection
Martins, M., Nooruzzaman, M., Cunningham, J. L., Ye, C., Caserta, L. C., Jackson, N., Martinez-Sobrido, L., Fang, Y., Diel, D. G.
10.1101/2023.10.09.561473 — Posted: 2023-10-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).